Parlar Sulunay, Bayraktar Gulsah, Tarikogullari Ayse Hande, Alptüzün Vildan, Erciyas Ercin
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University.
Chem Pharm Bull (Tokyo). 2016;64(9):1281-7. doi: 10.1248/cpb.c16-00221.
A series of pyridinium salts bearing alkylphenyl groups at 1 position and hydrazone structure at 4 position of the pyridinium ring were synthesized and evaluated for the inhibition of both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes. The cholinesterase (ChE) inhibitory activity studies were carried out by using the Ellman's colorimetric method. All compounds displayed considerable AChE and BuChE inhibitory activity and some of the compounds manifested remarkable anti-AChE activity compared to the reference compound, galantamine. Among the title compounds, the series including benzofuran aromatic ring exhibited the best inhibitory activity both on AChE and BuChE enzymes. Compound 3b, 4-[2-(1-(benzofuran-2-yl)ethylidene)hydrazinyl]-1-(3-phenylpropyl)pyridinium bromide, was the most active compound with IC50 value of 0.23 (0.24) µM against enantiomeric excess (ee)AChE (human (h)AChE) while compound 3a, 4-[2-(1-(benzofuran-2-yl)ethylidene)hydrazinyl]-1-phenethylpyridinium bromide, was the most active compound with IC50 value of 0.95 µM against BuChE. Moreover, 3a and b exhibited higher activity than the reference compound galantamine (eeAChE (hAChE) IC50 0.43 (0.52) µM; BuChE IC50 14.92 µM). Molecular docking studies were carried out on 3b having highest inhibitory activity against AChE.
合成了一系列在吡啶环的1位带有烷基苯基基团且在4位带有腙结构的吡啶盐,并对其抑制乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)的活性进行了评估。采用埃尔曼比色法进行胆碱酯酶(ChE)抑制活性研究。所有化合物均表现出相当的AChE和BuChE抑制活性,与参考化合物加兰他敏相比,一些化合物表现出显著的抗AChE活性。在标题化合物中,包含苯并呋喃芳环的系列对AChE和BuChE酶均表现出最佳抑制活性。化合物3b,4-[2-(1-(苯并呋喃-2-基)亚乙基)肼基]-1-(3-苯基丙基)吡啶溴化物是活性最高的化合物,对对映体过量(ee)AChE(人(h)AChE)的IC50值为0.23(0.24)μM,而化合物3a,4-[2-(1-(苯并呋喃-2-基)亚乙基)肼基]-1-苯乙基吡啶溴化物是对BuChE活性最高的化合物,IC50值为0.95μM。此外,3a和3b表现出比参考化合物加兰他敏更高的活性(eeAChE(hAChE)IC50 0.43(0.52)μM;BuChE IC50 14.92μM)。对针对AChE具有最高抑制活性的3b进行了分子对接研究。